Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Consuelo Rodríguez Jiménez"'
Autor:
Priscila Matovelle, Bárbara Olivan-Blázquez, Rosa Magallón-Botaya, Ana García-Sangenís, Ramon Monfà, Rosa Morros, Alicia Navarro Sanmartín, Jesús Mateos-Nozal, Carmen Sáez Bejar, Consuelo Rodríguez Jiménez, Elena López Pérez, Carl Llor
Publikováno v:
Antibiotics, Vol 13, Iss 2, p 152 (2024)
Urinary tract infections (UTIs) are highly prevalent in long-term care facilities, constituting the most common infection in this setting. Our research focuses on analyzing clinical characteristics and antimicrobial prescriptions for UTIs in resident
Externí odkaz:
https://doaj.org/article/d3140cc8a70849029c91943e0bc83763
Autor:
Antonio Z. Gimeno-García, Goretti Hernández, José Luis Baute Dorta, Cristina Reygosa, Raquel de la Barreda, Alberto Hernandez-Bustabad, Carla Amaral, Yaiza Cedrés, Rocío del Castillo, David Nicolás-Pérez, Alejandro Jiménez, Onofre Alarcon-Fernández, Manuel Hernandez-Guerra, Rafael Romero, Inmaculada Alonso, Yanira González, Zaida Adrian, Domingo Hernandez, Laura Ramos, Marta Carrillo, Vanessa Felipe, Anjara Hernández, Consuelo Rodríguez-Jiménez, Enrique Quintero
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Objective: We tested the hypothesis that an enhanced bowel preparation strategy (EBS) improves colonic cleansing in patients at high risk for inadequate bowel cleansing (HRI).Methods: This prospective randomized clinical trial included consecutive HR
Externí odkaz:
https://doaj.org/article/b7004d09dc1f4d99969210c299458271
Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature
Autor:
Guillermo Burillo-Putze, John R. Richards, Consuelo Rodríguez-Jiménez, Alejandro Sanchez-Agüera
Publikováno v:
Expert Opinion on Pharmacotherapy. 23:693-702
Cannabinoid hyperemesis syndrome (CHS) is an uncommon but unique disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients who regularly smoke cannabis. The syndrome does not reliably respond to intravenous administrati
Autor:
Carlos Dueñas Gutierrez, Jesica Abadia-Otero, Ivan Cusacovich, Jose Ignacio Martín-González, Alberto Muela-Molinero, Luis Corral-Gudino, Roberto González-Fuentes, Ängela Ruíz de Temiño, Elena Tapia Moral, Francisca Cuadrado-Medina, Miguel Martín-Asenjo, Pablo Miramontes Gonzalez, Jose Luis Delgado Morales, Sandra Ines, Laura Abad-Manteca, Iciar Usategui-Martín, Tomás Ruíz-Albí, Sara Miranda-Riaño, Patricia Rodríguez-Fortúnez, Consuelo Rodríguez-Jiménez, Esperanza López-Franco, Miguel Marcos
Publikováno v:
Open Forum Infectious Diseases. 9
Background Pulse glucocorticoid therapy is used in COVID-19 infection. We evaluated the effectiveness of methylprednisolone 250 mg/d for 3 days vs. dexamethasone 6 mg/d for 10 days in patients with severe but not critical COVID-19 pneumonia. Methods
Autor:
María J. Pedrosa-Martínez, Paloma Gijón, Víctor Moreno-Torres, Consuelo Pedrós, Ferran Torres, Aránzazu Sancho-López, Ana Fernández-Cruz, Francisco Abad-Santos, Enrique Sánchez-Chica, Itziar de Pablo-López, Paulina García-López, Consuelo Rodríguez-Jiménez, Guillermo Prada-Ramallal, Rocío Sanjuan-Jimenez, Ana Aldea-Perona, Carolina Hernández-Carballo, Belén Ruiz-Antorán, Ruth M. Aparicio-Hernández, Lourdes Cabrera-García, E. Montané, Roser Llop-Rius, Josefa A. Aguilar-García, Clara M. Rosso-Fernández, Evelyn I. Ortiz-Barraza
Publikováno v:
Infectious Diseases and Therapy
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
BackgroundWe aimed to determine the impact of tocilizumab use in severe COVID-19 pneumonia mortality.MethodsWe performed a multicentre retrospective cohort study in 18 tertiary hospitals in Spain, from March to April 2020. Consecutive patients admitt
Autor:
Eduardo Salido, Armando Torres, Mar García-Saiz, Consuelo Rodríguez-Jiménez, Lourdes Pérez-Tamajón
Publikováno v:
Drug Metabolism and Personalized Therapy. 32
Background In transplant patients receiving de novo anticalcineurin-free sirolimus (SRL)-based immunosuppression, we determined the influence of cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette, sub-family B (MDR/TAP), member (ABCB1) genotypes o